Count de Money: What Are the Costs of Cancer ? (American Cancer Society Cancer Facts & Figures 2002-2013)

======================================
What Are the Costs of Cancer?
——————————————————————
National Institutes of Health (NIH) estimates:
——————————————————————
overall costs of cancer:
——————————————————————
2010 – $263.8 billion (2011)
2010☝$263.8 billion (2010)
2008👇$201.5 billion (2013)
2008☝$228.1 billion (2009)
2007☝$226.8 billion (2012)
2007☝$219.2 billion (2008)
2006👇$206.3 billion (2007)
2005☝$209.9 billion (2006)
2004☝$189.8 billion (2005)
2003☝$189.5 billion (2004)
2002☝$171.6 billion (2003)
2001☝$156.7 billion (2002)
——————————————————————
direct medical costs
(total of all health expenditures)
——————————————————————
2010 – $102.8 billion (2011)
2010☝$102.8 billion (2010)
2008👇$77.4 billion (2013)
2008👇$93.2 billion (2009)
2007☝$103.8 billion (2012)
2007☝$89.0 billion (2008)
2006☝$78.2 billion (2007)
2005☝$74.0 billion (2006)
2004☝$69.4 billion (2005)
2003☝$64.2 billion (2004)
2002☝$60.9 billion (2003)
2001☝$56.4 billion (2002)
——————————————————————
2008-2011 – indirect morbidity costs
(cost of lost productivity due to illness)
——————————————————————
2010 – $20.9 billion (2011)
2010☝$20.9 billion (2010)
2008☝$18.8 billion (2009)
2007☝$18.2 billion (2008)
2006☝$17.9 billion (2007)
2005☝$17.5 billion (2006)
2004☝$16.9 billion (2005)
2003☝$16.3 billion (2004)
2002👇$15.5 billion (2003)
2001☝$15.6 billion (2002)
——————————————————————
indirect mortality costs
(cost of lost productivity due to premature death)
——————————————————————
2010 – $140.1 billion (2011)
2010☝$140.1 billion (2010)
2008☝$124.0 billion (2013)
2008👇$116.1 billion (2009)
2007☝$123.0 billion (2012)
2007☝$112.0 billion (2008)
2006👇$110.2 billion (2007)
2005☝$118.4 billion (2006)
2004👇$103.5 billion (2005)
2003☝$109 billion (2004)
2002☝$95.2 billion (2003)
2001☝$84.7 billion (2002)
——————————————————————
According to US Census Bureau:
——————————————————————
Americans uninsured
2012-2013 had no health insurance coverage
——————————————————————
2010👇approximately 50 million (2013)
2009 – almost 51 million (2012)
2009☝almost 51 million (2011)
2008☝46 million (2010)
——————————————————————
2008 – approximately 28% aged 18 to 34 years (2010)
——————————————————————
2010👇almost one-third of Hispanics (31%) (2013)
2009 – almost one-third of Hispanics (32%) (2012)
2009☝almost one­-third of Hispanics (32%) (2011)
——————————————————————
2011-2012 (17 years of age and younger)
2010-2012 – had no health insurance coverage
——————————————————————
2010 – one in 10 children (2013)
2009 – one in 10 children (2012)
2009 – one in 10 children (2011)
2008 – 10% of children (2010)
——————————————————————
2012-2013 PLEASE NOTE:

These numbers are not comparable to those published in previous years as of 2011, NIH calculating estimates using different data source:

2012 – NIH is using a different data source:

2012-2013 Medical Expenditure Panel Survey (MEPS) of the Agency for Healthcare Research and Quality

2012-2013 MEPS estimates based on more current, nationally representative data used extensively in scientific publications

2012-2013 direct and indirect costs will no longer be projected to current year, estimates of indirect morbidity costs discontinued

2012-2013 For more information, please visit nhlbi.nih.gov/about/factpdf.htm.
——————————————————————
Lack of health insurance and other barriers prevents many Americans from receiving optimal health care
——————————————————————
2008 – early release estimates from National Health Interview Survey (2009)
2006 – early release estimates from the National Health Interview Survey (2008)
2004 – National Health Interview Survey data (2007)
2003 – National Health Interview Survey data (2006)
——————————————————————
2008 – about 24% aged 18 to 64 years (2009)
2006☝about 24% aged 18-64 (2008)
2004 – about 17% younger than age 65 had no health insurance coverage (2007)
2003☝about 17% younger than age 65 have no health insurance coverage (2006)
——————————————————————
2004 – 27% 65 and older had Medicare coverage only (2007)
2003☝24% 65 and older have Medicare coverage only (2006)
——————————————————————
2008 – 13% of children had no health insurance coverage for at least part of past year (2009)
2006☝13% of children had no health insurance coverage for at least part of past year (2008)
——————————————————————
2008 – More than 36% of adults who lack high school diploma were uninsured in past year (2009)
2006☝Almost 34% of adults who lack high school diploma were uninsured in past year (2008)
——————————————————————
2008 – 23% of high school graduates (2009)
2006☝23% of high school graduates (2008)
——————————————————————
2008👇14% of those with more than high school education (2009)
2006 – 15% of those with more than high school education (2008)
——————————————————————
2008 – Lack of health insurance is not only a concern of unemployed; almost one-quarter of employed individuals (aged 18 to 64 years) were uninsured sometime during past year (2009)
——————————————————————
2004 – Persons in lowest income group 10 times as likely as persons in highest income group not to receive needed medical care because of cost (2007)
——————————————————————
2004 – Almost 16 million citizens (6%) were unable to obtain needed medical care due to cost (2007)
——————————————————————
2003 – In survey, nearly 20% aged 18-44 years reported not having usual place to go for medical care (2006)
——————————————————————
2010-2013 – Uninsured patients and ethnic minorities substantially more likely to be diagnosed with cancer at later stage, when treatment can be more extensive and more costly
——————————————————————
2012-2013 – For more information on relationship between health insurance and cancer, see Cancer Facts & Figures 2008, Special Section, available online at cancer.org/statistics.
2010 – cancer.org.
2009 – (5008.08), Special Section, available online at cancer.org.
2008 – see special section page 22

======================================
REFERENCES:
======================================
2013:
——————————————————————

Click to access acspc-036845.pdf

======================================
2012:
——————————————————————

Click to access acspc-031941.pdf

======================================
2011:
——————————————————————

Click to access acspc-029771.pdf

======================================
2010:
——————————————————————

Click to access acspc-024113.pdf

======================================
2009:
——————————————————————

Click to access 500809webpdf.pdf

======================================
2008:
——————————————————————

Click to access worldcancer.pdf

=====================================
2007:
——————————————————————

Click to access caff2007pwsecuredpdf.pdf

======================================
2006:
——————————————————————

Click to access caff2006pwsecuredpdf.pdf

======================================
2005:
——————————————————————

Click to access caff2005f4pwsecuredpdf.pdf

======================================
2004:
——————————————————————

Click to access CancerRates2004.pdf

======================================
2003:
——————————————————————

Click to access 2003_ACS_Cancer_Facts.pdf

======================================
2002:
——————————————————————

Click to access CancerFacts&Figures2002.pdf

======================================

Advertisement

Childhood Cancers (American Cancer Society: Cancer Facts & Figures 2006-2013)

======================================
2006-2013 – Childhood Cancer (Ages 0-14 years)
——————————————————————
Estimated new cases expected to occur
——————————————————————
2013 – 11,630
2012 – 12,060
2011 – 11,210
2010 – 10,700
2009 – 10,730
2008 – 10,730
2007 – 10,400
2006 – 9,500
——————————————————————
Estimated cancer deaths expected to occur
——————————————————————
about 1/3rd from leukemia
——————————————————————
2013 – 1,310
2012 – 1,340
2011 – 1,320
2010 – 1,340
2009 – 1,380
2008 – 1,490
2007 – 1,545
2006 – 1,560
——————————————————————
Major categories of pediatric cancer and more specific symptoms include:
——————————————————————
According to International Classification of Childhood Cancer, childhood cancers include: (2008-2010)
——————————————————————
• Leukemia (31% of all childhood cancers, including benign brain tumors) 2013
• Leukemia (34% of all childhood cancers) 2011-2012
• Leukemia (31.0% of all childhood cancers) 2010
• Leukemia (32.7% of all childhood cancers) 2009
• Leukemia (32.6% of all childhood cancers) 2008
• Leukemia (30% of all childhood cancers) 2007
• Leukemia (30%) 2006
may be recognized by:
bone and joint pain
weakness
pale skin
bleeding or bruising
fever or infection
——————————————————————
• Brain and other central nervous system tumors (25%) 2013
• Brain and other nervous system (27%) 2012
• Brain and other nervous system (27%) in early stages (2011)
(21.3%), which in early stages (2010)
• Brain and other nervous system (20.7%) in early stages (2009)
• Brain and other nervous system (21.1%) in early stages (2008)
• Brain and other nervous system (22.3%) in early stages (2007)
• Brain and other nervous system (22.3%) in early stages (2006)
may cause:
headaches
nausea
vomiting
blurred or double vision
dizziness
difficulty walking or handling objects
——————————————————————
• Neuroblastoma (6%) 2013
• Neuroblastoma (7%) 2012
• Neuroblastoma (7%) 2011
cancer of sympathetic nervous system
• Neuroblastoma (7.1%) (2010)
• Neuroblastoma (6.9%) (2009)
• Neuroblastoma (6.7%) (2008)
cancer of the sympathetic nervous system, can appear anywhere
• Neuroblastoma (7.3%) (2007)
• Neuroblastoma (7.3%) (2006)
cancer of nervous system
most common in children younger than 5 years of age
usually appears as swelling in abdomen
——————————————————————
• Wilms tumor (5%) 2013
• Wilms tumor (5%) 2012
• Wilms tumor (5%) 2011
• Wilms tumor (5.2%) 2010
• Wilms tumor (4.8%) 2009
• Wilms tumor (4.9%) 2008
• Wilms tumor (5.6%) 2006-2007
kidney cancer
may be recognized by swelling or lump in abdomen
——————————————————————
• Non-Hodgkin lymphoma (4%) and Hodgkin lymphoma (4%) 2013
• Non-Hodgkin lymphoma (4%) and Hodgkin lymphoma (4%) 2011-2012
• Non-Hodgkin lymphoma (4.3%) and Hodgkin lymphoma (3.8%) 2010
• Non-Hodgkin lymphoma (4.3%) and Hodgkin lym- phoma (3.6%) 2009
• Non-Hodgkin lymphoma (4.2%) and Hodgkin lymphoma (3.7%) 2008
• Non-Hodgkin lymphoma (4.5%) and Hodgkin lymphoma (3.5%) 2007
• Hodgkin lymphoma (3.5%) and non-Hodgkin lymphoma (4.5%) 2006
affect lymph nodes
may involve:
bone marrow and other organs (2013)
may spread to bone marrow and other organs (2006-2012)
may cause swelling of lymph nodes in:
neck
armpit
groin
as well as weakness and fever
——————————————————————
• Rhabdomyosarcoma (3%) 2011-2013
• Rhabdomyosarcoma (3.3%) 2010
• Rhabdomyosarcoma (3.5%) 2008-2009
• Rhabdomyosarcoma (3.1%) 2006-2007
soft tissue sarcoma
can occur in:
head and neck
genitourinary area
trunk
extremities
may cause pain and/or mass or swelling
——————————————————————
• Osteosarcoma (3%) 2011-2013
• Osteosarcoma (2.5%) 2010
• Osteosarcoma (2.7%) 2008-2009
• Osteosarcoma (2.4%) 2006-2007
bone cancer
most often occurs in adolescents commonly appears as sporadic pain in affected bone that may worsen at night or with activity, with eventual progression to local swelling
often has no initial pain or symptoms until local swelling begins (2006-2009)
——————————————————————
• Retinoblastoma (2%) 2013
• Retinoblastoma (3%) 2011-2012
• Retinoblastoma (2.6%) 2010
• Retinoblastoma (2.7%) 2009
• Retinoblastoma (2.8%) 2006-2008
eye cancer
usually occurs in children younger than 5 years of age
usually occurs in children younger than 4 years (2006-2010)
typically recognized because of discoloration behind pupil (2013)
typically recognized because of discoloration of eye pupil (2010-2012)
——————————————————————
• Ewing sarcoma (1%) 2011-2013
• Ewing sarcoma (1.6%) 2010
• Ewing sarcoma (1.4%) 2006-2009
type of cancer
usually arises in bone
most common in adolescents
typically appears as pain at tumor site
most often occurs in adolescents (2009-2011)
——————————————————————
Signs of childhood cancer include:
Symptoms of childhood cancer include: (2010-2011)
unusual mass or swelling
unexplained paleness or loss of energy
sudden increase in tendency to bruise or bleed
sudden tendency to bruise
(2006-2011)
persistent, localized pain
prolonged, unexplained fever or illness
frequent headaches, often with vomiting
sudden eye or vision changes
excessive, rapid weight loss
——————————————————————
2005-2009 – 0.6% per year
2004 to 2008 – 5% per year consistent trend since 1975
Overall, childhood cancer incidence rates have been increasing slightly 0.6% per year since 1975
Overall, childhood cancer incidence rates increased slightly
most recent 5 years of available data
——————————————————————
cancer is 2nd leading cause of death in children, exceeded only by accidents
——————————————————————
Childhood cancers are rare, representing less than 1% of all new cancer diagnoses
——————————————————————
2009 – 2.1 (per 100,000)
2008 – 2.2 (per 100,000)
1969 – 6.5 (per 100,000)
Mortality rates from childhood cancer have declined
2013 – 68% – over past 4 decades
2012 – 66% – over past 4 decades
2011 – 55% since 1975
2010 – 53% since 1975
2009 – 50% since 1975
2008 – since 1975 – almost 50%
2007 – 48% since 1975
2006 – since 1975 – about 48% –
——————————————————————
5-year survival among children (0-14 years of age) For most recent time period
——————————————————————
Rates vary considerably, depending on cancer type
——————————————————————
(1995- 2001) – 79% – for all sites combined
——————————————————————
(2002-2008) – 98% – retinoblastoma
——————————————————————
(2002-2008) – 96% – Hodgkin lymphoma
(2001-2007) – 95% – Hodgkin lymphoma
(1999­-2006) – 95% – Hodgkin lymphoma
(1999-2005) – 94% – Hodgkin lymphoma
(1996-2004) – 96% – Hodgkin lymphoma
(1996-2003) – 95% – Hodgkin lymphoma
(1996-2002) – 95% – Hodgkin lymphoma
(1995- 2001) – 95% – Hodgkin lymphoma
——————————————————————
(2002-2008) – 89% – Wilms tumor
(2001-2007) – 88% – Wilms tumor
(1999­-2006) – 89% – Wilms tumor
(1999-2005) – 88% – Wilms tumor
(1996-2004) – 92% – Wilms tumor
(1996-2003) – 92% – Wilms tumor
(1996-2002) – 92% – Wilms tumor
(1995- 2001) – 92% – Wilms tumor
——————————————————————
(2002-2008) – 86% – non-Hodgkin lymphoma
(2001-2007) – 86% – non-Hodgkin lymphoma
(1999­-2006) – 85% – non­Hodgkin lymphoma
(1999-2005) – 85% – non-Hodgkin lymphoma
(1996-2004) – 86% – non-Hodgkin lymphoma
(1996-2003) – 87% – non-Hodgkin lymphoma
(1996-2002) – 86% – non-Hodgkin lymphoma
——————————————————————
(2002-2008) – 84% – leukemia
(2001-2007) – 83% – leukemia
(1999­-2006) – 82% – leukemia
(1999-2005) – 82% – leukemia
(1996-2004) – 82% – leukemia
(1996-2003) – 81% – leukemia
(1996-2002) – 81% – leukemia
(1995- 2001) – 80% – leukemia
——————————————————————
(2002-2008) – 75% – neuroblastoma
(2001-2007) – 74% – neuroblastoma
(1999­-2006) – 73% – neuroblastoma
(1999-2005) – 74% – neuroblastoma
(1996-2004) – 70% – neuroblastoma
(1996-2003) – 69% – neuroblastoma
(1996-2002) – 69% – neuroblastoma
(1995- 2001) – 66% – neuroblastoma
——————————————————————
(2002-2008) – 75% – Ewing tumors
——————————————————————
(1996-2004) – 71% – bone and joint
(1996-2003) – 72% – bone and joint
(1996-2002) – 72% – bone and joint
(1995- 2001) – 71% – bone and joint
——————————————————————
(2002-2008) – 71% – brain and other central nervous system tumors
(2001-2007) – 71% – brain and other nervous system tumors
(1999­-2006) – 71% – brain and other nervous system
(1999-2005) – 71% – brain and other nervous system
(1996-2004) – 74% – brain and other nervous system
(1996-2003) – 74% – brain and other nervous system
(1996-2002) – 74% – brain and other nervous system
(1995- 2001) – 73% – brain and other nervous system
——————————————————————
(2002-2008) – 71% – osteosarcoma
(2001-2007) – 70% – osteosarcoma
(1999­-2006) – 70% – osteosarcoma
(1999-2005) – 69% – osteosarcoma
——————————————————————
(2002-2008) – 68% – rhabdomyosarcoma
(2001-2007) – 68% – rhabdomyosarcoma
(1999­-2006) – 66% – rhabdomyosarcoma
(1999-2005) – 66% – rhabdomyosarcoma
——————————————————————
Trends in 5-year Relative Survival Rates* (%) by Race, US, 1975-2008 (2013)
——————————————————————
Trends in 5-year Relative Survival Rates* (%) by Race, US, 1975-2007 (2012)
——————————————————————
Trends in 5-year Relative Survival Rates* (%) by Race and Year of Diagnosis, US, 1975-2006 (2011)
——————————————————————
Trends in 5-year Relative Survival Rates* (%) by Race and Year of Diagnosis, US, 1975-2005 (2010)
——————————————————————
Trends in 5-year Relative Survival Rates* (%) by Race and Year of Diagnosis, US, 1975-2004 (2009)
——————————————————————
Trends in 5-Year Relative Survival Rates* (%) by Race and Year of Diagnosis, US, 1975-2003 (2008)
——————————————————————
Trends in 5-Year Relative Survival* Rates (%) by Race and Year of Diagnosis, US, 1975-2002 (2007)
——————————————————————
Trends in 5-Year Relative Survival Rates* (%) by Race and Year of Diagnosis, US, 1974-2001 (2006)
——————————————————————
Brain & other nervous system
Brain (2006-2012)
——————————————————————
All races
——————————————————————
2002-2008 – 35% (2013)
2001-2007 – 35% (2013)
1999-2006 – 36% (2012)
1999-2005 – 36% (2010)
1996-2004 – 35% (2009)
1996-2003 – 35% (2008)
1996-2002 – 34% (2007)
1995-2001 – 33% (2006)
1987-1989 – 29% (2013)
1984-1986 – 29% (2012)
1984-1986 – 29% (2010)
1984-1986 – 29% (2009)
1984-1986 – 29% (2008)
1984-1986 – 29% (2007)
1983-1985 – 27% (2006)
1975-1977 – 24% (2012)
1975-1977 – 24% (2010)
1975-1977 – 24% (2009)
1975-1977 – 24% (2008)
1975-1977 -24% (2007)
1975-1977 – 22% (2013)
1974-1976 – 22% (2006)
——————————————————————
White
——————————————————————
2002-2008 – 34% (2013)
2001-2007 – 34% (2013)
1999-2006 – 35% (2012)
1999-2005 – 35% (2010)
1996-2004 – 34% (2009)
1996-2003 – 34% (2008)
1996-2002 – 34% (2007)
1995-2001 – 33% (2006)
1987-1989 – 28% (2013)
1984-1986 – 28% (2012)
1984-1986 – 28% (2010)
1984-1986 – 28% (2009)
1984-1986 – 28% (2008)
1984-1986 – 28% (2007)
1983-1985 – 26% (2006)
1975-1977 – 23% (2012)
1975-1977 – 23% (2010)
1975-1977 – 23% (2009)
1975-1977 – 23% (2008)
1975-1977 – 23% (2007)
1975-1977 – 22% (2013)
1974-1976 – 22% (2006)
——————————————————————
African American
——————————————————————
2002-2008 – 41% (2013)
2001-2007 – 40% (2013)
1999-2006 – 41% (2012)
1999-2005 – 41% (2010)
1996-2004 – 39% (2009)
1996-2003 – 37% (2008)
1996-2002 – 37% (2007)
1995-2001 – 38% (2006)
1987-1989 – 32%
1987-1989 – 31%
1984-1986 – 33% (2009)
1984-1986 – 33% (2008)
1984-1986 – 32% (2012)
1984-1986 – 32% (2010)
1984-1986 – 32% (2007)
1983-1985 – 32% (2006)
1975-1977 – 27% (2012)
1975-1977 – 27% (2010)
1975-1977 – 27% (2009)
1975-1977 – 27% (2008)
1975-1977 – 26% (2007)
1974-1976 – 26% (2006)
1975-1977 – 25% (2013)
——————————————————————
For all childhood cancers combined, 5-year relative survival rate has improved markedly over past 30 years due to new and improved treatments
——————————————————————
5-year relative survival rate increased for diagnoses
——————————————————————
Relative 5-Year Survival Rate (%)
——————————————————————
(2002-2008) – 83% in most recent time period
today – 83% (2012)
today – 80% (2011)
today – 80% (2010)
today – 80% (2009)
today – 80% (2008)
today – nearly 80% (2007)
in late 1990s – nearly 80% (2006)
mid-1970s – 58%
1970s – less than 50% before
due to new and improved treatments (2011)
1970s – less than 50% before (2010)
before 1970s – less than 50% (2006-2009)
rates vary considerably depending on
cancer type
patient age
other characteristics
——————————————————————
Survival for all invasive childhood cancers combined has improved markedly over the past 30 years due to new and improved treatments
——————————————————————
rates vary considerably depending on:
cancer type
patient age
other characteristics
patient characteristics (2011)
moreover, within major categories, cancer subtypes may vary in response to treatment and/or survival characteristics (2010)
——————————————————————
substantial progress in reducing childhood cancer mortality largely attributable to improvements in treatment and high rates of participation in clinical trials

substantial progress in childhood cancer largely attributable to improvements in treatment and high propor­tion of pediatric patients participating in clinical trials (2012)

substantial progress in childhood cancer survival rates largely attributable to improvements in treatment and high proportion of patients participating in clinical trials (2011)

substantial progress in pediatric cancer survival rates is attributable largely to improved treatments and high proportion of patients participating in clinical trials (2008-2009)
——————————————————————
Childhood cancers can be treated by combination of therapies
surgery
radiation
chemotherapy
chosen based on type and stage of cancer (2006-2012)
——————————————————————
Treatment is coordinated by team of experts, including: (2006-2012)
pediatric oncologists
pediatric nurses
social workers
psychologists
and others who assist chil­ dren and their families
——————————————————————
If child is eligible, placement in a clinical trial, which compares new treatment to best current treatment, should also be considered (2011-2012)

If child is eligible, placement in clinical trial, which compares best current treatment to new treatment, should also be considered (2010)

If patient is eligible, placement in clinical trial should also be considered (2008-2009)
——————————————————————
Because these cancers are uncommon, outcomes are more successful when treatment is managed by children’s cancer center (2008-2012)
——————————————————————
Early symptoms usually nonspecific
——————————————————————
Parents should ensure children have regular medical check-ups and be alert to any unusual, persistent symptoms

Parents should ensure children have regular medical checkups and be alert to any unusual symptoms that persist (2006-2012)
——————————————————————
Pediatric cancer patients may experience treatment-related side effects long after active treatment (2013)

Pediatric cancer patients may experience treatment-related side effects not only during treatment, but many years after diagnosis as well (2012)

Pediatric cancer patients may experience treatment ­related side effects not only at time of treatment, but several years after diagnosis as well (2011)

Survivors of childhood cancer may experience treatment-related side effects (2006-2010)
——————————————————————
Late treatment effects include:
impairment in function of specific organs
organ malfunction (2006-2010)
secondary cancers
cognitive deficits (2013)
cognitive impairments (2006-2012)
——————————————————————
The Children’s Oncology Group (COG) has developed long-term follow-up guidelines for screening and management of late effects in survivors of childhood cancer
——————————————————————
For more information on childhood cancer management
http://www.survivorshipguidelines.org
——————————————————————
The Childhood Cancer Survivor Study, has followed more than 14,000 long-term childhood cancer survivors, provided important and valuable information about late effects of cancer treatment
ccss.stjude.org
——————————————————————
(Proportions are provided for all races combined and may vary according to race/ethnicity.) 2010-2012
======================================
REFERENCES:
======================================
2013:
——————————————————————

Click to access acspc-036845.pdf

======================================
2012:
——————————————————————

Click to access acspc-031941.pdf

======================================
2011:
——————————————————————

Click to access acspc-029771.pdf

======================================
2010:
——————————————————————

Click to access acspc-024113.pdf

======================================
2009:
——————————————————————

Click to access 500809webpdf.pdf

======================================
2008:
——————————————————————

Click to access worldcancer.pdf

=====================================
2007:
——————————————————————

Click to access caff2007pwsecuredpdf.pdf

======================================
2006:
——————————————————————

Click to access caff2006pwsecuredpdf.pdf

======================================

The War on Cancer (I don’t think it means, what you think it says it means) #Winning?

“In 1971, the ACS (American Cancer Society) aggressively campaigned President Nixon to declare the “War on Cancer,” claiming that this could be won, given increased funding for the National Cancer Institute (NCI)“

“President Nixon responded by increasing its funding by $200,000”

“This was in excess of the funding that it then received as one of 30 other National Institutes of Health”

“In so doing, President Nixon effectively created an independent status for the NCI“ [0]
——————————————————————
American Cancer Society
——————————————————————
Cancer Facts & Figures 2002-2013
——————————————————————
Expected New Cancer Cases – USA
——————————————————————
2013☝1,660,290 – (21,380 more than 2012)
2012☝1,638,910 – (42,240 more than 2011)
2011☝1,596,670 – (67,160 more than 2010)
2010☝1,529,560 – (49,810 more than 2009)
2009☝1,479,350 – (42,170 more than 2008)
2008👇1,437,180 – ( 7,740 less than 2007)
2007☝1,444,920 – (45,130 more than 2006)
2006☝1,399,790 – (26,880 more than 2005)
2005☝1,372,910 – ( 4,870 more than 2004)
2004☝1,368,030 – (33,930 more than 2003)
2003☝1,334,100 – (49,200 more than 2002)
2002 – 1,284,900
——————————————————————
Expected to Die – United States
——————————————————————
2013☝580,350_-_(3,160 more than 2012)
2012☝577,190_-_(5,240 more than 2011)
2011☝571,950_-_(2,460 more than 2010)
2010☝569,490_-_(7,150 more than 2009)
2009👇562,340_-_(3,310 less than 2008)
2008☝565,650_-_(6,000 more than 2007)
2007👇559,650_-_(5,180 less than 2006)
2006👇564,830_-_(5,450 less than 2005)
2005☝570,280_-_(6,580 more than 2004
2004☝563,700_-_(7,200 more than 2003)
2003☝556,500_-_(6,000 more than 2002)
2002_-_555,500
——————————————————————
Deaths – United States of America
——————————————————————
2013 – almost 1,600 a day
2012 – 1,500+ a day
2011 – 1,500+ a day
2010 – 1,500+ a day
2009 – 1,500+ a day
2008 – 1,500+ a day
2007 – 1,500+ a day
2006 – 1,500+ a day
2005 – 1,500+ a day
2004 – 1,500+ a day
2003 – 1,500+ a day
======================================
Estimated Childhood Cancer Deaths (0-14 years)
——————————————————————
2013👇1, 310
2012☝1,340
2011👇1,320
2010👇1,340
2009👇1,380
2008👇1,490
2007👇1,545
2006👇1,560
2005☝1,585
2004☝1,510
2003☝1,500
2002 – 1,400
——————————————————————
Estimated New Childhood Cancer (0-14 years)
——————————————————————
2013👇11,630
2012☝12,060
2011☝11,210
2010👇10,700
2009 – 10,730
2008☝10,730
2007☝10,400
2006👇9,500
2005☝9,510
2004☝9,200
2003👇9,000
2002 – 9,100
======================================
Estimated Brain and other nervous system Cancer Deaths (Women)
——————————————————————
2013☝6,150 (2%)
2012☝5,980 (2%)
2011👇5,670 (2%)
2010☝5,720 (2%)
2009👇5,590 (2%)
2008☝5,650 (2%)
2007☝5,590 (2%)
2006☝5,560 (2%)
2005👇5,480 (2%)
2004👇5,490 (2%)
2003👇5,800 (2%)
2002 – 5,900 (2%)
======================================
Estimated All Cancer Deaths (Women)
——————————————————————
2013👇273,430 (100%)
2012☝275,370 (100%)
2011☝271,520 (100%)
2010☝270,290 (100%)
2009👇269800 (100%)
2008☝271,530 (100%)
2007👇270,100 (100%)
2006👇273,560 (100%)
2005☝275,000 (100%)
2004☝272,810 (100%)
2003☝270,600 (100%)
2002_-_267,300 (100%)
——————————————————————
Estimated Lung and bronchus Cancer Deaths (Women)
——————————————————————
2013👇72,220 (26%)
2012☝72,590 (26%)
2011☝71,340 (26%)
2010☝71,080 (26%)
2009👇70,490 (26%)
2008☝71,030 (26%)
2007👇70,880 (26%)
2006👇72,130 (26%)
2005☝73,020 (27%)
2004👇68,510 (25%)
2003☝68,800 (25%)
2002 – 65,700 (25%)
——————————————————————
Estimated Breast Cancer Deaths (Women)
——————————————————————
2013☝39,620 (14%)
2012👇39,510 (14%)
2011👇39,520 (15%)
2010👇39,840 (15%)
2009👇40,170 (15%)
2008☝40,480 (15%)
2007👇40,460 (15%)
2006☝40,970 (15%)
2005👇40,410 (15%)
2004☝40,110 (15%)
2003☝39,800 (15%)
2002 – 39,600 (15%)
——————————————————————
Estimated Colon and rectum Cancer Deaths (Women)
——————————————————————
2013👇24,530 (9%)
2012☝25,220 (9%)
2011👇24,130 (9%)
2010👇24,790 (9%)
2009👇24,680 (9%)
2008👇25,790 (9%)
2007👇26,180 (10%)
2006👇27,300 (10%)
2005👇27,750 (10%)
2004👇28,410 (10%)
2003 – 28,800 (11%)
2002 – 28,800 (11%)
——————————————————————
Estimated Pancreas Cancer Deaths (Women)
——————————————————————
2013☝18,970 (7%)
2012☝18,540 (7%)
2011☝18,300 (7%)
2010☝18,030 (7%)
2009☝17,210 (6%)
2008☝16,790 (6%)
2007☝16,530 (6%)
2006☝16,210 (6%)
2005☝15,980 (6%)
2004☝15,830 (6%)
2003☝15,300 (16%)
2002 – 15,200 (16%)
——————————————————————
Estimated Ovary Cancer Deaths (Women)
——————————————————————
2013👇14,030 (5%)
2012☝15,500 (6%)
2011☝15,460 (6%)
2010👇13,850 (5%)
2009👇14,600 (5%)
2008☝15,520 (6%)
2007👇15,280 (6%)
2006👇15,310 (6%)
2005☝16,210 (6%)
2004☝16,090 (6%)
2003☝14,300 (5%)
2002 – 13,900 (5%)
——————————————————————
Estimated Leukemia Deaths (Women)
——————————————————————
2013☝10,060 (4%)
2012☝10,040 (4%)
2011👇9,040 (3%)
2010👇9,180 (3%)
2009☝9,280 (3%)
2008👇9,250 (3%)
2007👇9,470 (4%)
2006👇9,810 (4%)
2005👇10,030 (4%)
2004☝10,310 (4%)
2003☝9,800 (4%)
2002 – 9,600 (4%)
——————————————————————
Estimated Non-Hodgkin lymphoma Deaths (Women)
——————————————————————
2013👇8,430 (3%)
2012👇8,620 (3%)
2011☝9,570 (4%)
2010👇9,500 (4%)
2009☝9,670 (4%)
2008☝9,370 (3%)
2007☝9,060 (3%)
2006👇8,840 (3%)
2005☝9,050 (3%)
2004👇9,020 (3%)
2003👇11,200 (4%)
2002 – 11,700 (4%)
——————————————————————
Estimated Uterine corpus Cancer Deaths (Women)
——————————————————————
2013☝8,190 (3%)
2012👇8,010 (3%)
2011☝8,120 (3%)
2010☝7,950 (3%)
2009☝7,780 (3%)
2008☝7,470 (3%)
2007☝7,400 (3%)
2006☝7,350 (3%)
2005☝7,310 (3%)
2004☝7,090 (3%)
2003☝6,800 (3%)
2002 – 6,600 (2%)
——————————————————————
Estimated Liver and intrahepatic bile duct Cancer Deaths (Women)
——————————————————————
2013☝6,780 (2%)
2012☝6,570 (2%)
2011☝6,330 (2%)
2010☝6,190 (2%)
2009☝6,070 (2%)
2008☝5,840 (2%)
2007 – 5,500 (2%)
2006
2005
2004
2003
2002
——————————————————————
Estimated Multiple myeloma Cancer Deaths (Women)
——————————————————————
2013
2012
2011
2010
2009
2008
2007
2006👇5,630 (2%)
2005 – 5,640 (2%)
2004☝5,640 (2%)
2003☝5,500 (2%)
2002 – 5,300 (2%)
======================================
Estimated New Cancer All (Women)
——————————————————————
2013☝805,500 (100%)
2012☝790,740 (100%)
2011☝774,370 (100%)
2010☝739,940 (100%)
2009☝713,220 (100%)
2008☝692,000 (100%)
2007👇678,060 (100%)
2006☝679,510 (100%)
2005👇662,870 (100%)
2004☝668,470 (100%)
2003☝658,800 (100%)
2002_-_647,400 (100%)
——————————————————————
Estimated New Breast Cancer (Women)
——————————————————————
2013☝232,340 (29%)
2012👇226,870 (29%)
2011☝238,480 (30%)
2010☝207,090 (28%)
2009☝192,370 (27%)
2008☝182,460 (26%)
2007👇178,480 (26%)
2006☝212,920 (31%)
2005👇211,240 (32%)
2004☝215,900 (32%)
2003☝211,300 (32%)
2002_-_203,500 (31%)
——————————————————————
Estimated New Lung and bronchus Cancer (Women)
——————————————————————
2013☝110,110 (14%)
2012☝109,690 (14%)
2011☝106,070 (14%)
2010☝105,770 (14%)
2009☝103,350 (14%)
2008☝100,330 (14%)
2007☝98,620 (15%)
2006☝81,770 (12%)
2005👇79,560 (12%)
2004☝80,660 (12%)
2003☝80,100 (12%)
2002 – 79,200 (12%)
——————————————————————
Estimated New Colon and rectum Cancer (Women)
——————————————————————
2013👇69,140 (9%)
2012☝70,040 (9%)
2011👇69,360 (9%)
2010👇70,480 (10%)
2009👇71,380 (10%)
2008👇71,560 (10%)
2007👇74,630 (11%)
2006☝75,810 (11%)
2005☝73,470 (11%)
2004👇73,320 (11%)
2003👇74,700 (11%)
2002 – 75,700 (12%)
——————————————————————
Estimated New Uterine corpus Cancer (Women)
——————————————————————
2013☝49,560 (6%)
2012☝47,130 (6%)
2011☝46,470 (6%)
2010☝43,470 (6%)
2009☝42,160 (6%)
2008☝41,100 (6%)
2007👇39,080 (6%)
2006☝41,200 (6%)
2005☝40,880 (6%)
2004👇40,320 (6%)
2003☝41,00 (6%)
2002 – 39,300 (6%)
——————————————————————
Estimated New Thyroid Cancer (Women)
——————————————————————
2013☝45,310 (6%)
2012☝43,210 (5%)
2011☝36,550 (5%)
2010☝33,930 (5%)
2009👇27,200 (4%)
2008☝28,410 (4%)
2007☝25,480 (4%)
2006☝22,590 (3%)
2005☝19,190 (3%)
2004☝17,640 (3%)
2003☝16,300 (3%)
2002 – 15,800 (2%)
——————————————————————
Estimated New Non-Hodgkin lymphoma (Women)
——————————————————————
2013☝32,140 (4%)
2012☝31,970 (4%)
2011☝30,300 (4%)
2010☝30,160 (4%)
2009👇29,990 (4%)
2008☝30,660 (4%)
2007☝28,990 (4%)
2006☝28,190 (4%)
2005☝27,320 (4%)
2004☝25,520 (4%)
2003👇25,100 (4%)
2002 – 25,700 (4%)
——————————————————————
Estimated New Melanoma of the skin Cancer (Women)
——————————————————————
2013👇31,630 (4%)
2012☝32,000 (4%)
2011☝30,220 (4%)
2010👇29,260 (4%)
2009☝29,640 (4%)
2008☝27,530 (4%)
2007👇26,030 (4%)
2006☝27,930 (4%)
2005☝26,000 (4%)
2004☝25,200 (4%)
2003☝24,300 (3%)
2002 – 23,500 (4%)
——————————————————————
Estimated New Kidney and renal pelvis Cancer (Women)
——————————————————————
2013☝24,720 (3%)
2012☝24,520 (4%)
2011☝23,800 (3%)
2010☝22,870 (3%)
2009☝22,330 (3%)
2008☝21,260 (3%)
2007 – 19,600 (3%)
2006
2005
2004
2003
2002
——————————————————————
Estimated New Pancreas Cancer (Women)
——————————————————————
2013☝22,489 (3%)
2012👇21,830 (3%)
2011☝21,980 (3%)
2010☝21,770 (3%)
2009 21,420 (3%)
2008
2007
2006☝16,580 (2%)
2005👇16,080 (2%)
2004☝16,120 (2%)
2003☝15,800 (2%)
2002 – 15,600 (2%)
——————————————————————
Estimated New Ovary Cancer (Women)
——————————————————————
2013👇22,240 (3%)
2012☝22,280 (3%)
2011☝21,990 (3%)
2010☝21,880 (3%)
2009👇21,550 (3%)
2008👇21,650 (3%)
2007☝22,430 (3%)
2006👇20,180 (3%)
2005👇22,220 (3%)
2004☝25,580 (4%)
2003☝25,400 (4%)
2002 – 23,300 (4%)
——————————————————————
Estimated New Leukemia (Women)
——————————————————————
2013
2012
2011
2010
2009
2008👇19,090 (3%)
2007 – 19,440 (3%)
2006
2005
2004
2003
2002
——————————————————————
Estimated New Urinary bladder Cancer (Women)
——————————————————————
2013
2012
2011
2010
2009
2008
2007
2006☝16,730 (2%)
2005☝16,200 (2%)
2004☝15,600 (2%)
2003 – 15,200 (2%)
2002 – 15,200 (2%)
======================================
Estimated All Cancer Deaths (Men)
——————————————————————
2013☝306,920 (100%)
2012☝301,820 (100%)
2011☝300,430 (100%)
2010☝299,200 (100%)
2009👇292,540 (100%)
2008☝294,120 (100%)
2007👇289,550 (100%)
2006👇291,270 (100%)
2005☝295,280 (100%)
2004☝290,890 (100%)
2003👇285,900 (100%)
2002_-_288,200 (100%)
——————————————————————
Estimated Lung and bronchus Deaths (Men)
——————————————————————
2013👇87,260 (28%)
2012☝87,750 (29%)
2011👇85,600 (28%)
2010👇86,220 (29%)
2009👇88,900 (30%)
2008☝98,810 (31%)
2007👇89,510 (31%)
2006👇90,330 (31%)
2005👇90,490 (31%)
2004☝91,930 (32%)
2003👇88,400 (31%)
2002 – 89,200 (31%)
——————————————————————
Estimated Prostate Cancer Deaths (Men)
——————————————————————
2013☝29,720 (10%)
2012👇28,170 (9%)
2011☝33,720 (11%)
2010☝32,050 (11%)
2009👇27,360 (9%)
2008☝28,660 (10%)
2007👇27,050 (9%)
2006👇27,350 (9%)
2005☝30,350 (10%)
2004☝29,500 (10%)
2003👇28,900 (10%)
2002 – 30,200 (11%)
——————————————————————
Estimated Colon and rectum Cancer Deaths (Men)
——————————————————————
2013👇26,300 (9%)
2012☝26,470 (9%)
2011👇25,250 (8%)
2010☝26,580 (9%)
2009☝25,240 (9%)
2008👇24,260 (8%)
2007👇26,000 (9%)
2006👇27,870 (10%)
2005☝28,540 (10%)
2004☝28,320 (10%)
2003☝28,300 (10%)
2002 – 27,800 (10%)
——————————————————————
Estimated Pancreas Cancer Deaths (Men)
——————————————————————
2013☝19,480 (6%)
2012👇18,850 (6%)
2011☝19,360 (3%)
2010☝18,770 (6%)
2009☝18,030 (6%)
2008☝17,500 (6%)
2007☝16,840 (6%)
2006☝16,090 (6%)
2005☝15,820 (5%)
2004☝15,440 (5%)
2003☝14,700 (5%)
2002 – 14,500 (5%)
——————————————————————
Estimated Liver and intrahepatic bile duct Cancer Deaths (Men)
——————————————————————
2013☝14,890 (5%)
2012☝13,980 (5%)
2011☝13,260 (4%)
2010☝12,720 (4%)
2009👇12,090 (4%)
2008☝12,570 (4%)
2007☝11,280 (4%)
2006☝10,840 (4%)
2005☝10,330 (3%)
2004☝9,450 (3%)
2003☝9,200 (3%)
2002 – 8,900 (3%)
——————————————————————
Estimated Leukemia Deaths (Men)
——————————————————————
2013☝13,660 (4%)
2012☝13,500 (4%)
2011☝12,740 (4%)
2010☝12,660 (4%)
2009☝12,590 (4%)
2008☝12,460 (4%)
2007👇12,320 (4%)
2006👇12,470 (4%)
2005👇12,540 (4%)
2004☝12,990 (5%)
2003 – 12,100 (4%)
2002 – 12,100 (4%)
——————————————————————
Estimated Esophagus Cancer Deaths (Men)
——————————————————————
2013☝12,220 (4%)
2012☝12,040 (4%)
2011☝11,910 (4%)
2010☝11,650 (4%)
2009☝11,490 (4%)
2008☝11,250 (4%)
2007☝10,900 (4%)
2006☝10,730 (4%)
2005☝10,530 (4%)
2004☝10,250 (4%)
2003☝9,900 (4%)
2002 – 9,600 (3%)
——————————————————————
Estimated Urinary bladder Cancer Deaths (Men)
——————————————————————
2013☝10,820 (4%)
2012👇10,510 (3%)
2011☝10,670 (4%)
2010☝10,410 (3%)
2009☝10,180 (3%)
2008☝9,950 (3%)
2007☝9,630 (3%)
2006☝8,990 (3%)
2005☝8,970 (3%)
2004☝8,780 (3%)
2003 – 8,600 (3%)
2002 – 8,600 (3%)
——————————————————————
Estimated Non-Hodgkin lymphoma Deaths (Men)
——————————————————————
2013☝10,590 (3%)
2012☝10,320 (3%)
2011👇9,750 (3%)
2010☝10,710 (4%)
2009☝9,830 (3%)
2008☝9,790 (3%)
2007👇9,600 (3%)
2006👇10,000 (3%)
2005👇10,150 (3%)
2004👇10,390 (4%)
2003👇12,200 (4%)
2002 – 12,700 (5%)
——————————————————————
Estimated Kidney and renal pelvis Cancer Deaths (Men)
——————————————————————
2013☝8,780 (3%)
2012☝8,650 (3%)
2011☝8,270 (3%)
2010☝8,210 (3%)
2009☝8,160 (3%)
2008☝8,100 (3%)
2007👇8,080 (3%)
2006☝8,130 (3%)
2005☝8,020 (3%)
2004☝7,870 (3%)
2003☝7,409 (3%)
2002 – 7,200 (3%)
======================================
Estimated New Cancer All (Men)
——————————————————————
2013☝854,790 (100%)
2012☝848,170 (100%)
2011☝822,300 (100%)
2010☝789,620 (100%)
2009☝766,130 (100%)
2008👇745,180 (100%)
2007☝766,860 (100%)
2006☝720,280 (100%)
2005☝710,040 (100%)
2004☝699,560 (100%)
2003☝675,300 (100%)
2002_-_637,500 (100%)
——————————————————————
Estimated New Prostate Cancer (Men)
——————————————————————
2013👇238,590 (28%)
2012☝241,470 (29%)
2011☝240,890 (29%)
2010☝217,730 (28%)
2009☝192,280 (25%)
2008👇186,320 (25%)
2007👇218,890 (29%)
2006☝234,460 (33%)
2005☝232,090 (33%)
2004☝230,110 (33%)
2003☝220,900 (33%)
2002_-_189,000 (30%)
——————————————————————
Estimated New Lung and bronchus Cancer (Men)
——————————————————————
2013☝118,080 (14%)
2012☝116,470 (14%)
2011👇115,060 (14%)
2010☝116,750 (15%)
2009☝116,090 (15%)
2008👇114,690 (15%)
2007☝114,760 (15%)
2006👇92,700 (13%)
2005👇93,010 (13%)
2004☝93,110 (13%)
2003☝91,800 (14%)
2002 – 90,200 (14%)
——————————————————————
Estimated New Colon and rectum Cancer (Men)
——————————————————————
2013☝73,680 (13%)
2012☝73,420 (9%)
2011👇71,850 (9%)
2010👇72,090 (9%)
2009👇75,590 (10%)
2008👇77,250 (10%)
2007☝79,130 (10%)
2006☝72,800 (10%)
2005👇71,820 (10%)
2004☝73,620 (11%)
2003☝72,800 (11%)
2002 – 72,600 (11%)
——————————————————————
Estimated New Urinary bladder Cancer (Men)
——————————————————————
2013👇54,610 (6%)
2012☝55,600 (7%)
2011👇52,020 (6%)
2010👇52,760 (7%)
2009☝52,810 (7%)
2008☝51,230 (7%)
2007☝50,040 (7%)
2006👇44,690 (6%)
2005☝47,010 (7%)
2004☝44,640 (6%)
2003☝42,200 (6%)
2002 – 41,500 (7%)
——————————————————————
Estimated New Melanoma of the skin Cancer (Men)
——————————————————————
2013☝45,060 (5%)
2012☝44,250 (5%)
2011☝40,010 (5%)
2010👇38,870 (5%)
2009☝39,080 (5%)
2008☝34,950 (5%)
2007👇33,910 (4%)
2006☝34,260 (5%)
2005☝33,580 (5%)
2004 – 29,900 (4%)
2003👇29,900 (4%)
2002 – 30,100 (5%)
——————————————————————
Estimated New Kidney and renal pelvis Cancer (Men)
——————————————————————
2013☝40,430 (5%)
2012☝40,250 (5%)
2011☝37,120 (5%)
2010👇35,370 (4%)
2009☝35,430 (5%)
2008☝33,130 (4%)
2007☝31,590 (4%)
2006☝24,650 (3%)
2005☝22,490 (3%)
2004☝22,080 (3%)
2003☝19,500 (3%)
2002 – 19,100 (3%)
——————————————————————
Estimated New Non-Hodgkin lymphoma (Men)
——————————————————————
2013👇37,600 (4%)
2012☝38,160 (4%)
2011☝36,060 (4%)
2010👇35,380 (4%)
2009☝35,990 (5%)
2008☝35,450 (5%)
2007☝34,200 (4%)
2006☝30,680 (4%)
2005☝29,070 (4%)
2004☝28,850 (4%)
2003☝28,300 (4%)
2002 – 28,200 (4%)
——————————————————————
Estimated New Oral cavity and pharynx Cancer (Men)
——————————————————————
2013☝29,620 (3%)
2012☝28,540 (3%)
2011☝27,710 (3%)
2010☝25,420 (3%)
2009👇25,240 (3%)
2008☝25,310 (3%)
2007☝24,180 (3%)
2006☝20,180 (3%)
2005☝19,100 (3%)
2004☝18,550 (3%)
2003👇18,200 (3%)
2002 – 18,900 (3%)
——————————————————————
Estimated New Leukemia (Men)
——————————————————————
2013☝27,880 (3%)
2012☝26,830 (3%)
2011☝25,320 (3%)
2010👇24,690 (3%)
2009☝25,630 (3%)
2008☝25,180 (3%)
2007☝24,800 (3%)
2006☝20,000 (3%)
2005☝19,640 (3%)
2004☝19,020 (3%)
2003☝17,900 (3%)
2002 – 17,600 (3%)
——————————————————————
Estimated New Pancreas Cancer (Men)
——————————————————————
2013☝22,740 (3%)
2012☝22,090 (3%)
2011☝22,050 (3%)
2010☝21,370 (3%)
2009☝21,050 (3%)
2008👇18,770 (3%)
2007☝18,830 (2%)
2006☝17,150 (2%)
2005☝16,109 (2%)
2004☝15,740 (2%)
2003☝14,900 (2%)
2002 – 14,700 (2%)
======================================

——————————————————————
American Cancer Society
——————————————————————
Cancer Facts & Figures
======================================
REFERENCES:
======================================
[0] – AMERICAN CANCER SOCIETY

More Interested In Accumulating Wealth Than Saving Lives

Samuel S. Epstein, M.D.

Emeritus professor Environmental and Occupational Medicine

University of Illinois School of Public Health

and

Chairman, The Cancer Prevention Coalition
——————————————————————
http://www.wnho.net/acs.pdf
======================================
2013
——————————————————————

Click to access acspc-036845.pdf

——————————————————————

Click to access acspc-036845.pdf

——————————————————————
http://cancer.org/research/cancerfactsstatistics/cancerfactsfigures2013/index
——————————————————————
http://m.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2013/index
——————————————————————
http://cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2013
——————————————————————
http://m.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2013
======================================
2012
——————————————————————

Click to access acspc-031941.pdf

——————————————————————

Click to access acspc-031941.pdf

——————————————————————
http://cancer.org/research/cancerfactsstatistics/cancerfactsfigures2012/index
——————————————————————
http://m.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2012/index
——————————————————————
http://cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2012
——————————————————————
http://m.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2012
======================================
2011
——————————————————————

Click to access acspc-029771.pdf

——————————————————————

Click to access acspc-029771.pdf

——————————————————————
http://cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2011
——————————————————————
http://m.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2011
======================================
2010
——————————————————————

Click to access acspc-024113.pdf

——————————————————————

Click to access acspc-024113.pdf

——————————————————————
http://cancer.org/research/cancerfactsstatistics/cancerfactsfigures2010/index
——————————————————————
http://m.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2010/index
======================================
2009
——————————————————————

Click to access 500809webpdf.pdf

——————————————————————

Click to access 500809webpdf.pdf

——————————————————————
http://cancer.org/research/cancerfactsstatistics/cancerfactsfigures2009/index
——————————————————————
http://m.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2009/index
——————————————————————
http://cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2009
——————————————————————
http://m.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2009
======================================
2008
——————————————————————

Click to access worldcancer.pdf

——————————————————————
http://cancer.org/research/cancerfactsstatistics/cancerfactsfigures2008/index
——————————————————————
http://m.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2008/index
——————————————————————
http://cancer.org/research/cancerfactsstatistics/allcancerfactsfigures/index
——————————————————————
http://m.cancer.org/research/cancerfactsstatistics/allcancerfactsfigures/index
======================================
2007
——————————————————————

Click to access caff2007pwsecuredpdf.pdf

——————————————————————

Click to access caff2007pwsecuredpdf.pdf

——————————————————————
http://cancer.org/research/cancerfactsstatistics/cancerfactsfigures2007/index
——————————————————————
http://m.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2007/index
——————————————————————
http://cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2007
——————————————————————
http://m.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2007
======================================
2006
——————————————————————

Click to access caff2006pwsecuredpdf.pdf

——————————————————————

Click to access caff2006pwsecuredpdf.pdf

——————————————————————
http://cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2006
——————————————————————
http://m.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2006
======================================
2005
——————————————————————

Click to access caff2005f4pwsecuredpdf.pdf

——————————————————————

Click to access caff2005f4pwsecuredpdf.pdf

——————————————————————
http://cancer.org/research/cancerfactsstatistics/allcancerfactsfigures/index
——————————————————————
http://m.cancer.org/research/cancerfactsstatistics/allcancerfactsfigures/index
——————————————————————
http://cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2005
——————————————————————
http://m.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2005
======================================
2004
——————————————————————

Click to access CancerRates2004.pdf

======================================
2003
——————————————————————

Click to access 2003_ACS_Cancer_Facts.pdf

======================================
2002
——————————————————————

Click to access CancerFacts&Figures2002.pdf

======================================